Drug Profile
Staphylococcal vaccine - Imaxio
Alternative Names: Bellerophon projectLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Imaxio
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Staphylococcal infections
Highest Development Phases
- No development reported Staphylococcal infections
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Staphylococcal-infections(Prevention) in France (Parenteral)
- 14 Jul 2016 Early research is ongoing in France
- 14 Jul 2016 Staphylococcal vaccine - Imaxio is available for licensing as of 14 Jul 2016. http://www.imaxio.com/